Rhinomune® - 5 Dose

Disease Description
Primary infection with EHV-1 causes an acute respiratory disease characterized by nasal discharge, coughing, labored breathing, fever, slight loss of appetite, and depression. Annual outbreaks may occur among foals in areas with a large equine population. Clinical signs, occasionally persisting as long as 7 days, are generally more severe in young horses, and may be exacerbated by strenuous activity. Subclinical reinfection may also occur, with latent carriers the probable reservoir of EHV-1.

Directions and Dosage
Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Shake well. Administer 1 mL intramuscularly. Use entire contents when first opened.

Primary Vaccination: Healthy horses 3 months of age or older should receive 2 doses administered 3-4 weeks apart. Foals should be vaccinated when maternal antibodies have declined, generally at 3 months of age. If vaccinated earlier, foals should receive the 2-dose series after reaching 3 months of age. Pregnant mares should be vaccinated after the second month of pregnancy.

Revaccination: Revaccination every 3 months with a single dose is recommended.

Precautions
Sterilized syringes and needles should be used for administration. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Do not vaccinate within 21 days before slaughter. Burn containers and all unused contents. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

VACCINES MUST BE REFRIGERATED AND SHIPPED NEXT DAY OR SECOND DAY AIR.

This product is not eligible for any discounts.